AREYOUOK | News on the latest health tech of Asian markets

Allovir Completed $120 Million Series B Round of Financing to Develop Multi-Virus-Specific T Cell Immunotherapy

05/23/2019

STORM Therapeutics Completed £14 Million Series A Financing, Focusing on the Development of Small Molecule Therapies for RNA Epigenetics

Takeda and Frazier Jointly Founded! Phathom Pharmaceuticals Completed $140 Million Financing to Develop Gastrointestinal Disease Therapy

VR Medical Platform Psious Completed 8 Million Euro Financing, Focusing on Mental Health Disease Treatment

Allovir Completed $120 Million Series B Round of Financing to Develop Multi-Virus-Specific T Cell...

05/23/2019

AlloVir, a Houston-based biotech company, completed a $120 million Series B round of financing. This round of financing was led by Fidelity Management and...

STORM Therapeutics Completed £14 Million Series A Financing, Focusing on the Development of Small...

05/22/2019

On May 20, 2019, local time, STORM Therapeutics completed a £14 million Series A round of financing. This round of financing was completed by...

Takeda and Frazier Jointly Founded! Phathom Pharmaceuticals Completed $140 Million Financing to Develop Gastrointestinal...

05/22/2019

Takeda Pharmaceutical and Frazier Healthcare Partners collaborated to create Phathom Pharmaceuticals. It is a biopharmaceutical company focusing on developing and commercializing new treatments for...

VR Medical Platform Psious Completed 8 Million Euro Financing, Focusing on Mental Health Disease...

05/21/2019

Psious, a behavioral health technology company in Barcelona, Spain, announced that it has completed a €8 million financing. The current round of funding was...

Paradigm Diagnostics Completed $15 Million B Series of Financing to Promote Commercialization of Proprietary...

05/20/2019

Paradigm Diagnostics completed $15 million in Series B financing. As part of this financing, Mara Aspinall, Managing Director of BlueStone Venture Partners, will join...